🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Trevena appoints new financial chief

Published 11/28/2024, 05:16 AM
TRVN
-

CHESTERBROOK, PA - Trevena Inc (OTC:TRVN)., a pharmaceutical company specializing in the development of treatments for gastrointestinal disorders, announced a change in its financial leadership on Monday. Katrine Sutton has been named the new principal financial officer and principal accounting officer of the company, effective immediately.

Sutton, 48, has been with Trevena since July 2019, serving as Vice President of Finance Planning and Analysis. Her experience includes a previous role as Vice President of Finance and Accounting at Synergy Pharmaceuticals Inc. She holds a Bachelor of Science in Accounting from the University of Richmond and is a Certified Public Accountant.

The board's decision to appoint Sutton comes as Barry Shin, the former principal financial officer and principal accounting officer, steps down from his role. According to the company's statement, Shin's departure is not due to any disagreement with the company's operations, policies, or practices.

In other recent news, Trevena Inc. has unveiled a series of executive changes aimed at enhancing operational efficiency. The pharmaceutical firm has terminated the employment of three key executives, including President and CEO Carrie L. Bourdow, EVP and CFO Barry Shin, and SVP and CMO Mark A. Demitrack. Despite this, the said officers will continue to play active roles in the company.

The terminations were part of a broader strategy to reduce costs, with no reported disagreements over operations, policies, or practices. As part of the transition, Trevena has entered into separation agreements with each executive, outlining their severance entitlements. These agreements have been filed with the SEC as part of the company's disclosure process.

In addition, Trevena has initiated consulting agreements with Shin and Demitrack, allowing them to provide advice on various business matters, including corporate strategy and commercial assets. The compensation for these consulting services aligns with their previous salary levels.

InvestingPro Insights

As Trevena Inc. (TRVN) undergoes this leadership transition, InvestingPro data provides additional context to the company's financial situation. Despite recent challenges, including a significant stock price decline of 90.03% year-to-date, Trevena maintains a strong liquidity position. An InvestingPro Tip highlights that the company's liquid assets exceed its short-term obligations, which could provide some financial flexibility as it navigates through this period of change.

Another InvestingPro Tip notes that Trevena holds more cash than debt on its balance sheet, potentially offering a buffer for ongoing operations and development efforts in the competitive pharmaceutical industry. However, investors should be aware that the company is not currently profitable, which aligns with its focus on developing novel therapies.

For those seeking a deeper understanding of Trevena's financial health and market position, InvestingPro offers 5 additional tips that could provide valuable insights for investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.